CRISPR screens identify gene targets and drug repositioning opportunities at breast cancer risk loci
Tuano, N. K.; Beesley, J.; Manning, M.; Shi, W.; Malver-Ortega, L.; Paynter, J.; Black, D.; Civitarese, A.; McCue, K.; Hatzipantelis, A.; Hillman, K.; Kaufmann, S.; Sivakumaran, H.; Polo, J. M.; Reddel, R.; Band, V.; French, J. D.; Edwards, S. L.; Powell, D.; Chenevix-Trench, G.; Rosenbluh, J.
Show abstract
Genome-wide association studies (GWAS) have identified >200 loci associated with breast cancer (BC) risk. The majority of candidate causal variants (CCVs) are in non-coding regions and are likely to modulate cancer risk by regulating gene expression. We recently developed a scoring system, INQUISIT, to predict candidate risk genes at BC-risk loci. Here, we used pooled CRISPR activation and suppression screens to validate INQUISIT predictions, and to define the cancer phenotypes they mediate. We measured proliferation in 2D, 3D, and in immune-deficient mice, as well as the effect on the DNA damage response. We performed 60 CRISPR screens and identified 21 high-confidence INQUISIT predictions that mediate a cancer phenotype. We validated the direct regulation of a subset of genes by BC-risk variants using HiCHIP and CRISPRqtl. Furthermore, we show the utility of expression profiling for drug repurposing against these targets. We provide a platform for identifying gene targets of risk variants, and lay a blueprint of interventions for BC risk reduction and treatment.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Germline and somatic genetic variants in the p53 pathway interact to affect cancer risk, progression and drug response 94%
- Aberrant transcript usage induces homologous recombination deficiency and predicts therapeutic responses 94%
- CIP2A interacts with TopBP1 and is selectively essential for DNA damage-induced basal-like breast cancer tumorigenesis 94%
Similar papers in this journal
- Co-regulation and functional cooperativity of FOXM1 and RHNO1 bidirectional genes in ovarian cancer 95%
- ZHX2 Promotes HIF1α Oncogenic Signaling in Triple-Negative Breast Cancer 95%
- Exosome component 1 cleaves single-stranded DNA and sensitizes kidney renal clear cell carcinoma cells to poly(ADP-ribose) polymerase inhibitor 95%
Similar papers in this journal
- Single-cell ATAC and RNA sequencing reveal pre-existing and persistent subpopulations of cells associated with relapse of prostate cancer 94%
- Prolonging lung cancer response to EGFR inhibition by targeting the selective advantage of resistant cells 94%
- The DiffInvex evolutionary model for conditional somatic selection identifies chemotherapy resistance genes in 10,000 cancer genomes 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.